Suppr超能文献

同种异体移植物冷冻保存在腹主动脉-髂动脉移植物感染中的长期结果。

Long-term results of cryopreserved allografts in aortoiliac graft infections.

机构信息

Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

Department of Cardiovascular Surgery, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.

出版信息

J Vasc Surg. 2021 Jul;74(1):268-275. doi: 10.1016/j.jvs.2020.12.070. Epub 2021 Mar 1.

Abstract

OBJECTIVE

Different graft materials have been proposed for in situ reconstruction in the setting of vascular graft infection (VGI). We analyzed the long-term outcomes after in situ aortoiliac reconstruction with cryopreserved allografts.

METHODS

We performed a retrospective analysis of patients who had undergone in situ aortoiliac reconstruction with cryopreserved arterial allografts for VGI from 2000 to 2015. The end points were the perioperative and long-term mortality and graft-related complications, including stenosis, occlusion, pseudoaneurysm, and reinfection.

RESULTS

A total of 33 patients (91% male) with a median age of 67 years (range, 53-83 years) had undergone in situ aortoiliac reconstruction with cryopreserved allografts. The 30-day mortality was 6% (n = 2); both deaths were related to the allograft (one early allograft-enteric fistula and one graft rupture). Another two patients had experienced early (≤30 days) graft-related events (one allograft-enteric fistula and one graft limb occlusion), for an early graft-related complication rate of 12% (n = 4). Of the 31 discharged patients, 13 (42%) had died after a median of 47 months (range, 2-97 months). The median follow-up for the 18 remaining patients was 96 months (range, 10-146 months). The estimated survival at 1, 3, and 5 years was 88%, 81%, and 66%, respectively. Nine patients (29%) had experienced at least one of the following graft-related events during follow-up, including graft stenosis requiring intervention in five (16%), graft occlusion in four (13%), pseudoaneurysm in three (10%), and reinfection in two patients (6%). The estimated freedom from any first graft-related event at 1, 3, and 5 years was 78%, 71%, and 62%, respectively. The estimated primary patency and primary assisted patency at 1 and 3 years was 87% and 79%, and 90% and 83%, respectively.

CONCLUSIONS

In situ aortoiliac reconstruction with cryopreserved allografts to treat VGI was associated with relevant perioperative graft-related complications. Although the reinfection rate was acceptable, other graft-related complications were frequent in the long term, in particular, graft occlusion and stenosis.

摘要

目的

在血管移植物感染(VGI)的情况下,已经提出了不同的移植物材料用于原位重建。我们分析了冷冻保存同种异体移植物用于 VGI 时的原位腹主动脉重建的长期结果。

方法

我们对 2000 年至 2015 年间接受冷冻保存动脉同种异体移植物原位腹主动脉重建治疗 VGI 的患者进行了回顾性分析。终点为围手术期和长期死亡率以及移植物相关并发症,包括狭窄、闭塞、假性动脉瘤和再感染。

结果

共有 33 名(91%为男性)中位年龄 67 岁(范围,53-83 岁)的患者接受了冷冻保存同种异体移植物的原位腹主动脉重建。30 天死亡率为 6%(n=2);两次死亡均与移植物有关(一次早期移植物-肠瘘,一次移植物破裂)。另外两名患者在早期(≤30 天)发生了移植物相关事件(一次移植物-肠瘘和一次移植物支闭塞),早期移植物相关并发症发生率为 12%(n=4)。31 名出院患者中,中位随访 47 个月(范围,2-97 个月)后有 13 名(42%)死亡。其余 18 名患者的中位随访时间为 96 个月(范围,10-146 个月)。估计 1、3 和 5 年的生存率分别为 88%、81%和 66%。9 名患者(29%)在随访期间至少经历了一次以下移植物相关事件,包括 5 名患者(16%)需要干预的移植物狭窄、4 名患者(13%)的移植物闭塞、3 名患者(10%)的假性动脉瘤和 2 名患者(6%)的再感染。估计 1、3 和 5 年时无任何首次移植物相关事件的患者比例分别为 78%、71%和 62%。估计 1 年和 3 年的原发性通畅率和原发性辅助通畅率分别为 87%和 79%,90%和 83%。

结论

用冷冻保存同种异体移植物治疗 VGI 的原位腹主动脉重建与相关的围手术期移植物相关并发症有关。尽管再感染率是可以接受的,但其他移植物相关并发症在长期内较为常见,特别是移植物闭塞和狭窄。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验